All times listed are Central Time Zone.
| 8:00 AM |
Breakfast & Check-in |
| 9:00 AM |
Welcome William Gradishar, MD |
|
SESSION 1
New Considerations in Breast Cancer Session Moderator: Nora Hansen, MD | |
| 9:05 AM |
Obesity, Menopause, Metabolic Biomarkers Erin Giles, PhD |
| 9:35 AM |
GLP-1 Drugs and Breast Cancer Neil Iyengar, MD |
| 10:05 AM |
Sustainability and Breast Cancer Martin O’Sullivan, MD |
| 10:35 AM |
AI Tools for Clinical Practice Emily Ray, MD |
| 11:05 AM |
Controversies in Breast Reconstruction Babak Mehrara, MD |
| 11:35 AM |
Q&A |
| 12:00 PM |
Lunch |
| 1:00 PM |
Awards |
|
SESSION 2
Breast Pathology for the Non-Pathologist Session Moderator: Kalliopi Siziopikou, MD, PhD | |
| 1:15 PM |
The Ever-Changing Field of Breast Tumor Biomarkers Hannah Wen, MD, PhD |
| 1:45 PM |
The Spectrum of the Phyllodes Tumors of the Breast Bill Li, MD, PhD |
| 2:15 PM |
Diagnostic Pitfalls in Breast Pathology Ashley Cimino-Mathews, MD |
| 2:45 PM |
Artificial Intelligence (AI) in Breast Pathology; Excitement and Doubts Kalliopi Siziopikou, MD, PhD |
| 3:15 PM |
Q&A |
| 3:35 PM |
Break |
| 3:55 PM |
Unusual Cases Panel Moderator: William Gradishar, MD; Panel: Confirmed speakers |
| 5:15 PM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | Non-CME | |
| 7:30 AM |
Breakfast & Check-in |
|
SESSION 3
Imaging & Risk Session Moderator: Seema Khan, MD | |
| 8:30 AM |
Genetic Syndromes Associated with Male Breast Cancer Claudine Isaacs, MD |
| 9:00 AM |
Molecular Underpinnings of Disparity in Breast Cancer Neha Goel, MD |
| 9:30 AM |
Imaging Strategies to Reduce Disparity Maxine Jochelson, MD |
| 10:00 AM |
Break |
| 10:20 AM |
PET Scanning with Newer Tracers Gary Ulaner, MD |
| 10:50 AM |
Q&A |
| 11:10 AM |
LYNN SAGE DISTINGUISHED LECTURE From Radical to Rational: The Remarkable Evolution of Loco-regional Management in Breast Cancer Terry Mamounas, MD |
| 12:10 PM |
Lunch |
|
SESSION 4
Challenges in Lobular Carcinoma and Optimal Endocrine Therapy Session Moderator: Janice Lu, MD | |
| 1:30 PM |
Biology of Lobular Cancer Steffi Oesterreich, PhD |
| 2:00 PM |
Surgical Issues in Lobular Cancer Tari King, MD |
| 2:30 PM |
Systemic Issues in Lobular Cancer Rachel Jankowitz, MD |
| 3:00 PM |
Break |
| 3:20 PM |
Sequencing Endocrine Therapy in HR+ Disease William Gradishar, MD |
| 3:50 PM |
Novel SERDS Virginia Kaklamani, MD, DSc |
| 4:20 PM |
Q&A |
| 4:45 PM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | Non-CME | |
| 7:30 AM |
Breakfast & Check-in |
|
SESSION 5
Triple Negative Breast Cancer Session Moderator: William Gradishar, MD | |
| 8:30 AM |
Mimics of TN Breast Cancer Edi Brogi, MD |
| 9:00 AM |
Managing Non-pCR after NAC Joyce O’Shaunghnessy, MD |
| 9:30 AM |
Selecting the Right RT for the Right patient TBA |
| 10:00 AM |
Systemic Therapy for TN Cancer in 2025 Heather McArthur, MD |
| 10:30 AM |
Break |
| 11:00 AM |
Management of the Axilla after NAC: ITCS,Micrometastases, and Macrometastases Tracy Moo, MD |
| 11:30 AM |
Q&A |
| 12:00 PM |
Lunch |
|
SESSION 6
Controversies in Management Session Moderator: Jonathan Stauss, MD, MBA | |
| 1:15 PM |
Molecular Minimal Residual Disease Dan Stover, MD |
| 1:45 PM |
Primary Endocrine Therapy 2025 Anthony Elias, MD |
| 2:15 PM |
Cryoablation for Local Control Sheldon Feldman, MD |
| 2:35 PM |
Preoperative RT to Facilitate Reconstruction Audree Tadros, MD |
| 2:55 PM |
Q&A |
| 3:25 PM |
Case Management Panel Moderators: Monica Morrow, MD; William Gradishar, MD; Panel: Nora Hansen, MD; Armando Giuliano, MD; Anthony Elias, MD; Eric Donnelly, MD |
| 5:00 PM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | Non-CME | |
| 7:30 AM |
Breakfast & Check-in |
|
SESSION 7
Omitting Surgery – The Ultimate De-escalation Session Moderator: Monica Morrow, MD | |
| 8:30 AM |
Omitting Sentinel Node Biopsy: Multidisciplinary Concerns - What does the data say? Armando Giuliano, MD |
| 9:00 AM |
Radiation Oncology Concerns Atif Khan, MD |
| 9:30 AM |
Medical Oncology Concerns Hal Burstein, MD |
| 10:00 AM |
Is it time to abandon surgery in DCIS? Monica Morrow, MD |
| 10:30 AM |
Q&A |
| 11:00 AM |
Adjourn |
|
View more agendas: Thursday | Friday | Saturday | Sunday | Non-CME | |
Optional educational activities are scheduled during times that do not conflict with the Symposium agenda and are not approved for CME or continuing education credit. The content of these optional non-CME activities and opinions expressed by presenters are those of the sponsor or presenters. Meals will be included with lunch and breakfast events.
Peer insights to help identify and manage candidates for treatment with a CDK4/6 inhibitor
Thursday, October 23 • lunch event
Presenter: Kelly McCann, MD, PhD, UCLA
sponsored by Eli Lilly
A 2L Treatment Option for HR+/HER2- aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET ± CDK4/6i
Friday, October 24 • lunch event
Presenter: Kit Lu, MD, UPMC Hillman Cancer Center
sponsored by AstraZeneca
Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBC
Saturday, October 25 • lunch event
Presenter: Neil Iyengar, MD, Emory University
sponsored by Gilead
The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3 days of formal presentations and interactive Q&A sessions.
The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list »
Optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.
